Literature DB >> 15820192

Protection in the aged heart: preventing the heart-break of old age?

Magdalena Juhaszova1, Christophe Rabuel, Dmitry B Zorov, Edward G Lakatta, Steven J Sollott.   

Abstract

The aged heart has a diminished functional and adaptive reserve capacity, an increased susceptibility to incur damage (e.g., as a result of ischemia), and a limited practical ability for repair/regeneration. Thus, there has been considerable interest to harness the heart's endogenous capacity to resist such damage, known as ischemic preconditioning (IPC), as well as other cardioprotective mechanisms. However, the translation of basic research findings into clinical practice has largely been inadequate because there have been few if any successful implementations in terms of viable therapies activating cardioprotection mechanisms to limit infarct size. Here, we provide an overview of the general mechanisms of cardioprotection, changes in the structure and function of the aged heart, and the current knowledge regarding cardioprotection in aged heart. The problems and opportunities for successful bench-to-bedside translation of cardioprotection in the elderly are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820192     DOI: 10.1016/j.cardiores.2004.12.020

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  55 in total

1.  Middle age aggravates myocardial ischemia through surprising upholding of complex II activity, oxidative stress, and reduced coronary perfusion.

Authors:  Evangelia Mourmoura; Marie Leguen; Hervé Dubouchaud; Karine Couturier; Damien Vitiello; Jean-Luc Lafond; Melanie Richardson; Xavier Leverve; Luc Demaison
Journal:  Age (Dordr)       Date:  2010-09-29

Review 2.  Regulation and pharmacology of the mitochondrial permeability transition pore.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Yael Yaniv; H Bradley Nuss; Su Wang; Steven J Sollott
Journal:  Cardiovasc Res       Date:  2009-05-15       Impact factor: 10.787

Review 3.  Role of glycogen synthase kinase-3beta in cardioprotection.

Authors:  Magdalena Juhaszova; Dmitry B Zorov; Yael Yaniv; H Bradley Nuss; Su Wang; Steven J Sollott
Journal:  Circ Res       Date:  2009-06-05       Impact factor: 17.367

4.  Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart.

Authors:  Claudia C Preston; Andrew S Oberlin; Ekhson L Holmuhamedov; Anu Gupta; Sandeep Sagar; Rashad H Khazi Syed; Sabeeh A Siddiqui; Sreekumar Raghavakaimal; Andre Terzic; Arshad Jahangir
Journal:  Mech Ageing Dev       Date:  2008-03-04       Impact factor: 5.432

Review 5.  Mitochondrial health, the epigenome and healthspan.

Authors:  Miguel A Aon; Sonia Cortassa; Magdalena Juhaszova; Steven J Sollott
Journal:  Clin Sci (Lond)       Date:  2016-08-01       Impact factor: 6.124

6.  Local delivery of a PKCε-activating peptide limits ischemia reperfusion injury in the aged female rat heart.

Authors:  T S Lancaster; S J Jefferson; D H Korzick
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-31       Impact factor: 3.619

Review 7.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Steven J Sollott
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

8.  Exercise training inducibility of MnSOD protein expression and activity is retained while reducing prooxidant signaling in the heart of senescent rats.

Authors:  John M Lawler; Hyo-Bum Kwak; Jong-Hee Kim; Min-Hwa Suk
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-18       Impact factor: 3.619

Review 9.  Estrogen and the female heart.

Authors:  A A Knowlton; D H Korzick
Journal:  Mol Cell Endocrinol       Date:  2014-01-22       Impact factor: 4.102

10.  Blueberry-enriched diet protects rat heart from ischemic damage.

Authors:  Ismayil Ahmet; Edward Spangler; Barbara Shukitt-Hale; Magdalena Juhaszova; Steven J Sollott; James A Joseph; Donald K Ingram; Mark Talan
Journal:  PLoS One       Date:  2009-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.